You are here: Industry Insights > Allergan

News List

FDA Accepts Supplemental New Drug Application for Allergan’s VRAYLAR americanpharmaceuticalreview
March 09, 2017
Allergan has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine), seeking the addition of new clinical data evaluating VRAYLAR for the maintena
Allergan CEO says "everybody" likely looking at Bristol-Myers Squibb: report firstwordpharma
February 24, 2017
Allergan CEO Brent Saunders suggested that a number of companies will be looking at Bristol-Myers Squibb as a potential takeover target given its share price decline over the past six months, Bloomberg reported Thursday.
Allergan to acquire US medical technology company Zeltiq for $2.47bn pharmaceutical-technology
February 15, 2017
Ireland-based biopharmaceutical company Allergan has signed an agreement to acquire US-based medical technology company Zeltiq Aesthetics in a deal valued at $2.47bn.
Allergan to Acquire ZELTIQ for $2.47B americanpharmaceuticalreview
February 14, 2017
Allergan and ZELTIQ® Aesthetics, Inc have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary adjustments.
Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9B in Fourth Quarter americanpharmaceuticalreview
February 10, 2017
Allergan has reported its fourth quarter and full year 2016 continuing operations performance. Fourth Quarter and Full-Year 2016 Continuing Operations
Allergan's fourth-quarter revenue climbs 7 percent, boosted by Botox sales firstwordpharma
February 09, 2017
Allergan announced Wednesday that fourth-quarter sales climbed 7.1 percent year-over-year to $3.9 billion, topping analyst estimates of $3.8 billion.
Allergan Completes LifeCell Acquisition americanpharmaceuticalreview
February 06, 2017
Allergan has successfully completed the acquisition of LifeCell Corporation, a leading regenerative medicine company. Allergan acquired LifeCell for approximately $2.9 billion in cash.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page